Virtus ETF Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Virtus ETF Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-74,688	Closed	-$929K	–	193
2016 Q4	$929K	Sell	74,688 -957	-1%	-$11.5K	0.28%	64
2016 Q3	$1.04M	Buy	75,645 +9,532	+14%	+$95.7K	0.5%	32
2016 Q2	$489K	Sell	66,113 -26,489	-29%	-$199K	0.36%	60
2016 Q1	$592K	Buy	+92,602	New	+$519K	0.82%	26

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Virtus ETF Advisers's ARIA Position: Q1 2017 in Review

Virtus ETF Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 74,688 shares — an estimated $929K sold.

Virtus ETF Advisers first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $1.04M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Virtus ETF Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Virtus ETF Advisers sold 74,688 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $929K.
Virtus ETF Advisers first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
Virtus ETF Advisers's Ariad Pharmaceuticals Inc position peaked at $1.04M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Virtus ETF Advisers's 13F filing for Q1 2017, filed 15 May 2017.